FindTrial
Sign In

A study to assess the symptom burden in cancer patients

A descriptive study to assess the symptom burden in cancer patients undergoing treatment in GGSMCH, Faridkot, Punjab. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104976
Enrollment
130
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Arshleen Kaur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients above 18 years diagnosed with cancer. Patients undergoing treatment in GGSMCH, Faridkot Patients available at the time of data collection.

Exclusion criteria

Exclusion criteria: Patients who are not willing to participate. Patients who are not able to respond due to severe illness.

Design outcomes

Primary

MeasureTime frame
symptom burden among cancer patients undergoing treatment as measured by rotterdam symptom checklist at a single point in timeTimepoint: symptom burden among cancer patients undergoing treatment as measured by rotterdam symptom checklist will be assesed at baseline—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactArshleen Kaur

University College of Nursing, Faridkot

arshleensaini@gmail.com9781084963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026